Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heleen Scheerens

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The New England Journal of Medicine|August 5, 2011
Lebrikizumab treatment in adults with asthmaJonathan Corren, Robert F Lemanske, Nicola A Hanania, et al.
Thorax|May 24, 2015
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studiesNicola A Hanania, Michael Noonan, Jonathan Corren, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2006
Novel, potent, selective, and orally bioavailable human betaII-tryptase inhibitorsDavid Sperandio, Vincent W-F Tai, Julia Lohman, et al.
Respiratory Research|March 20, 2016
A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthmaJeffrey M Harris, Romeo Maciuca, Mary S Bradley, et al.
Science Translational Medicine|July 4, 2014
Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE productionGail M Gauvreau, Jeffrey M Harris, Louis-Philippe Boulet, et al.
The Journal of Biological Chemistry|July 25, 2013
Development of a human IgG4 bispecific antibody for dual targeting of interleukin-4 (IL-4) and interleukin-13 (IL-13) cytokinesChristoph Spiess, Jack Bevers, Janet Jackman, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2015
Discovery of highly potent and selective Bruton's tyrosine kinase inhibitors: Pyridazinone analogs with improved metabolic stabilityWendy B Young, James Barbosa, Peter Blomgren, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2015
Potent and selective Bruton's tyrosine kinase inhibitors: discovery of GDC-0834Wendy B Young, James Barbosa, Peter Blomgren, et al.
ACS Medicinal Chemistry Letters|June 20, 2017
Discovery of Potent and Selective Tricyclic Inhibitors of Bruton's Tyrosine Kinase with Improved Druglike PropertiesXiaojing Wang, James Barbosa, Peter Blomgren, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The New England Journal of Medicine|August 5, 2011
Lebrikizumab treatment in adults with asthmaJonathan Corren, Robert F Lemanske, Nicola A Hanania, et al.
Thorax|May 24, 2015
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studiesNicola A Hanania, Michael Noonan, Jonathan Corren, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2006
Novel, potent, selective, and orally bioavailable human betaII-tryptase inhibitorsDavid Sperandio, Vincent W-F Tai, Julia Lohman, et al.
Respiratory Research|March 20, 2016
A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthmaJeffrey M Harris, Romeo Maciuca, Mary S Bradley, et al.
Science Translational Medicine|July 4, 2014
Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE productionGail M Gauvreau, Jeffrey M Harris, Louis-Philippe Boulet, et al.
The Journal of Biological Chemistry|July 25, 2013
Development of a human IgG4 bispecific antibody for dual targeting of interleukin-4 (IL-4) and interleukin-13 (IL-13) cytokinesChristoph Spiess, Jack Bevers, Janet Jackman, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2015
Discovery of highly potent and selective Bruton's tyrosine kinase inhibitors: Pyridazinone analogs with improved metabolic stabilityWendy B Young, James Barbosa, Peter Blomgren, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2015
Potent and selective Bruton's tyrosine kinase inhibitors: discovery of GDC-0834Wendy B Young, James Barbosa, Peter Blomgren, et al.
ACS Medicinal Chemistry Letters|June 20, 2017
Discovery of Potent and Selective Tricyclic Inhibitors of Bruton's Tyrosine Kinase with Improved Druglike PropertiesXiaojing Wang, James Barbosa, Peter Blomgren, et al.
Pageof 2